BMP Inhibition with dorsomorphin limits adipogenic potential of preadipocytes

J Vet Med Sci. 2010 Mar;72(3):373-7. doi: 10.1292/jvms.09-0442. Epub 2009 Dec 8.

Abstract

Previous studies revealed that bone morphogenetic protein (BMP) induces commitment to the adipocyte lineage in pluripotent stem cells. The present study explored the role of endogenous BMP activity in 3T3-L1 preadipocytes. The expression of phospho-Smad1/5/8 was monitored because BMP transmits its signal through Smad1/5/8 phosphorylation. Phosphorylated Smad1/5/8 was higher in proliferating preadipocytes, and lower in differentiating adipocytes after removing differentiation inducers. Reporter assays revealed that dorsomorphin predominantly inhibits the BMP pathway but not the structurally related TGF-beta/activin pathway. The addition of dorsomorphin to the culture medium prior to treatment with differentiation inducers impaired lipid accumulation in 3T3-L1 cells. The present study indicated that activation of BMP signaling in preadipocytes is required for these cells to initiate the adipogenic program.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells / cytology
  • 3T3-L1 Cells / drug effects
  • Adipocytes / cytology*
  • Adipocytes / drug effects
  • Adipose Tissue / cytology*
  • Adipose Tissue / drug effects
  • Animals
  • Bone Morphogenetic Proteins / antagonists & inhibitors*
  • Bone Morphogenetic Proteins / drug effects
  • Bone Morphogenetic Proteins / physiology
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Division / drug effects
  • Cell Division / physiology
  • Mice
  • Pyrazoles / pharmacology*
  • Pyrimidines / pharmacology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Bone Morphogenetic Proteins
  • Pyrazoles
  • Pyrimidines
  • dorsomorphin